41 results
8-K
EX-99.1
6vffq43rfrb1obp4t
4 Dec 23
Corporate Presentation December 2023 1
7:45am
8-K
EX-99.1
g4v4z qux
13 Nov 23
Corporate Presentation November 2023 1
5:10pm
8-K
EX-99.2
2hwvzm35 lxo3oc1i
8 Aug 23
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
7:33am
424B5
e7yeeb2wyl5rbk3csfqb
20 Jul 23
Prospectus supplement for primary offering
4:11pm
424B5
nk6yelsgbu5v0 6jv14
17 Jul 23
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.2
0e5fqc po
17 Jul 23
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human
6:06am
8-K
EX-3.1
iuhzquhy
8 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:20pm
8-K
EX-99.2
lnvs5rmwuh3qi 8m
9 May 23
Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights
7:08am
PRE 14A
p5yw9
14 Apr 23
Preliminary proxy
4:33pm
S-3
EX-4.2
hxyoe4j
1 Jul 22
Shelf registration
5:06pm
S-3
ov1b7vb
1 Jul 22
Shelf registration
5:06pm
DEF 14A
v4oidhjqg5m74k
27 Apr 22
Definitive proxy
5:03pm
10-K
hj5fdrjmysfb nckvxa
28 Mar 22
Annual report
4:51pm